AM
TMO icon

AGF Management’s Thermo Fisher Scientific TMO Stock Holding History

AGF Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103M Buy
208,842
+72,331
+53% +$39.3M 0.46% 68
2025
Q4 		$79.1M Buy
136,511
+48,763
+56% +$27.6M 0.34% 87
2025
Q3 		$42.6M Sell
87,748
-118,109
-57% -$55M 0.19% 119
2025
Q2 		$83.5M Buy
205,857
+9,130
+5% +$3.82M 0.38% 82
2025
Q1 		$97.9M Buy
196,727
+63,201
+47% +$34.2M 0.52% 60
2024
Q4 		$69.5M Sell
133,526
-29,704
-18% -$16.3M 0.35% 89
2024
Q3 		$101M Buy
163,230
+41,007
+34% +$24.3M 0.51% 62
2024
Q2 		$67.6M Sell
122,223
-50,500
-29% -$28.9M 0.38% 87
2024
Q1 		$100M Sell
172,723
-111,573
-39% -$62.6M 0.56% 57
2023
Q4 		$151M Buy
284,296
+39,564
+16% +$19.2M 0.89% 29
2023
Q3 		$124M Buy
244,732
+44,516
+22% +$23.7M 0.88% 28
2023
Q2 		$104M Buy
200,216
+64,950
+48% +$35M 0.76% 42
2023
Q1 		$78M Sell
135,266
-49,436
-27% -$27.9M 0.53% 63
2022
Q4 		$102M Buy
+184,702
New +$97.9M 0.74% 36

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AGF Management's TMO Position: Q1 2026 in Review

AGF Management increased its Thermo Fisher Scientific (TMO) stake by 53% in Q1 2026, buying an estimated $39.3M and bringing the position to 208,842 shares worth $103M. The position accounts for 0.46% of the portfolio, ranked #68.

AGF Management first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $151M in Q4 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AGF Management held 208,842 shares of Thermo Fisher Scientific worth $103M as of Q1 2026.
  • AGF Management bought 72,331 Thermo Fisher Scientific shares in Q1 2026, an estimated $39.3M.
  • Thermo Fisher Scientific made up 0.46% of AGF Management's portfolio in Q1 2026, its #68 holding.
  • AGF Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • AGF Management's Thermo Fisher Scientific position peaked at $151M in Q4 2023.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.